MRC1 and neoplasm: Addition of anti-CRD4-MR scFv #G11 (Fig. 5A, condition 6) and, to a lower extend, of scFv #B2 (Fig. 5A, condition 5), could inhibit the upregulation of CD206 and SR-A in CD206low macrophages co-cultured with tumor cells.